Additional file 5: of Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS

Abstract

Increase in the number of motor neurons in spinal cords of AMD3100 following treatment. SOD1G93A mice were treated with AMD3100 (n=3)or PBS (n=3) starting at 50 days old and sacrificed at 110 days old. Fifteen nonadjacent sections per group of lumbar spinal cords were stained with thionin and analyzed. Results are mean ¹ S.E.M. (TIF 191 kb